ILUMYA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 30 Apr 2025)
What this means for you
Registered since 15 Jan 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87835715
- Registration number
- 5657826
- Mark type
- Design + words
- Filed
- 15 Mar 2018
- Published for opposition
- 11 Sept 2018
- Registered
- 15 Jan 2019
- Attorney of record
- Craig Kuchii
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of inflammatory diseases, pharmaceutical preparations for the for prevention and treatment of auto immune system related diseases and disorders, pharmaceutical preparations for the treatment of immune system related diseases and disorders, pharmaceutical preparations for use in dermatology, pharmaceutical preparations for the treatment of skin diseases and disorders, pharmaceutical preparations for the treatment of psoriasis
Owner
- SUN PHARMACEUTICAL INDUSTRIES LIMITED, VADODARA, GUJARAT, IN
- Sun Pharma Global FZE, Sharjah, AE
- Sun Pharma Global FZE, Sharjah, AE
- Sun Pharma Global FZE, Sharjah, AE
Prosecution history
- 30 Apr 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 30 Apr 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 30 Apr 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 14 Jan 2025 — TEAS SECTION 8 & 15 RECEIVED
- 15 Jan 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 07 Sept 2022 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 15 Jan 2019 — REGISTERED-PRINCIPAL REGISTER
- 14 Dec 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Dec 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Dec 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 13 Nov 2018 — USE AMENDMENT FILED
- 01 Dec 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 13 Nov 2018 — TEAS STATEMENT OF USE RECEIVED
- 06 Nov 2018 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 11 Sept 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED